Modify or add data on this page

Medal - Lehn and Fink Pharmaceutical Science

Medal - Lehn and Fink (Pharmaceutical Science) - awersMedal - Lehn and Fink (Pharmaceutical Science) - reverse

© Retiredkp'er (CC BY-NC)

Features

Location United States
Type Award medals › Scholastic, academic and scientific awards
Composition Złoto (.5833) (14 K)
Weight 21.26 g
Diameter 38.8 mm
Thickness 1.5 mm
Shape Okrągły
Technique Frezowana
Number
N#
402101

Obverse

Waga za moździerzem i tłuczkiem nad okrągłą uszczelkąAutomatically translated

Script: łaciński

Lettering:
LEHN AND FINK INC MEDAL
FOR THE
ADVANCEMENT OF
PHARMACEUTICAL
SCIENCE

Reverse

Script: łaciński

Lettering:
AWARDED
TO
CARLE W. LYONS
OF THE COLLEGE
OF
PHARMACY
OF
CREIGHTON UNIVERSITY"

Edge

Zwykły z napisemAutomatically translated

Script: łaciński

Lettering: "14 K B.B.B."

Mint

Bailey, Banks and Biddle, Philadelphia, United States

Comments

Przyznawany absolwentowi z najlepszą średnią ocen w ciągu ostatnich czterech lat.

Automatically translated

Manage my collection

Please sign in or create an account to manage your collection.

Date VG F VF XF AU UNC
ND 

Get this item

No member from this site currently wants to exchange it.

Numista Rarity index: 100 Wskazówki wyszukiwania
This index is based on the data of Numista members collections. It ranges from 0 to 100, 0 meaning a very common coin or banknote and 100 meaning a rare coin or banknote among Numista members.
Bullion value: USD 1711.04 Wskazówki wyszukiwania
This value is given for information purpose only. It is based on a price of złoto at 137 977 USD/kg. Numista does not buy or sell coins or metal.
Actual złoto weight: 0.399 oz
Current złoto price: 4291.56 USD/oz (see gold price )

Related forum discussions

Discuss or ask a question

Contribute to the catalogue

Modify or add data on this page (in English)
Register a past auction sale
Register an example of this type
Duplicate this page (in English)
Cite this page: https://numista.com/402101 (copy permalink) Permalink copied
Share: Facebook X (Twitter)